Parkinson’s Disease Therapeutics Market

Parkinson’s Disease Therapeutics Market Size

Parkinson’s Disease Therapeutics Market Share

Parkinson’s disease therapeutics market USD 2.61 bn in 2018 & is expected to generate around USD 5.28 bn by 2025, at a CAGR of around 10.6% between 2019 & 2025.

SUITE N202, FLORIDA, UNITED STATES, October 10, 2022 /EINPresswire.com/ -- Zion Market Research has published a new report titled “𝐏𝐚𝐫𝐤𝐢𝐧𝐬𝐨𝐧’𝐬 𝐃𝐢𝐬𝐞𝐚𝐬𝐞 𝐓𝐡𝐞𝐫𝐚𝐩𝐞𝐮𝐭𝐢𝐜𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 by Drug Class (Levodopa Combination, Dopamine Agonists, Monoamine Oxidase B (MAO-B) Inhibitors, Anticholinergic Drugs, Catechol-O-Methyltransferase (COMT) Inhibitors, and Others), by Route of Administration (Oral, Transdermal, Subcutaneous, and Intestinal Infusion), and by Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Sales): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2018–2025”. According to the report, the global Parkinson’s disease therapeutics market was approximately USD 2.61 billion in 2018 and is expected to generate around USD 5.28 billion by 2025, at a CAGR of around 10.6% between 2019 and 2025.

Parkinson’s disease (PD) is a nervous system disorder that increases in severity with time. The disease is characterized by bradykinesia, rigidity, tremor, and postural instability. Some of the most common symptoms of Parkinson’s disease include arm, hand, or leg tremors, problems associated with balancing and walking, stiff muscles, and slow physical movements. Other symptoms include constipation, trouble swallowing, dementia, fixed or blank expressions, and speech disabilities. The global Parkinson’s disease therapeutics market is likely to be driven by the increasing research and development activities for the development of novel Parkinson’s disease therapeutic drugs and rising Parkinson’s disease incidences.

𝐑𝐞𝐪𝐮𝐞𝐬𝐭 𝐅𝐫𝐞𝐞 𝐒𝐚𝐦𝐩𝐥𝐞@https://www.zionmarketresearch.com/sample/parkinsons-disease-therapeutics-market

𝐎𝐮𝐫 𝐅𝐫𝐞𝐞 𝐒𝐚𝐦𝐩𝐥𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 𝐂𝐨𝐧𝐬𝐢𝐬𝐭𝐬 𝐨𝐟 𝐭𝐡𝐞 𝐟𝐨𝐥𝐥𝐨𝐰𝐢𝐧𝐠:

-The 2022 revised study includes a detailed industry analysis, introduction, and overview.
-The package contains the COVID-19 Pandemic Outbreak Impact Analysis.
-nearly 227 pages Report on Research (Including Recent Research)
-Give comprehensive chapter-by-chapter instructions on the Request
-Graphical Representation of Size, Share, and Trends for the Year 2022 for the Updated Regional Analysis
-Includes The updated tables and figures
-The Top Market Players, their Business Strategies, Sales Volume, and Revenue Analysis are all included in the most recent version of the study.
-Market research techniques from Zion

As per the Parkinson’s Foundation, around 8 to 10 million people worldwide are affected by Parkinson’s disease, and every year approximately 70,000 Americans are diagnosed with it.

Based on drug class, the market includes dopamine agonists, catechol-o-methyltransferase (COMT) inhibitors, anticholinergic drugs, levodopa combination, monoamine oxidase B (MAO-B) inhibitors, and others. The levodopa combination segment held a major share of the global market in 2018, as the levodopa combination therapy is among the highly effective treatments for controlling motor symptoms at different stages of Parkinson’s disease.

Based on the route of administration, the market includes transdermal, oral, subcutaneous, and intestinal infusion. The oral segment held a significant share of the global market in 2018. Additionally, the introduction of Duopa medicine in the U.S. contributed to a major share of the intestinal infusion segment in the global market.

The distribution channel of the Parkinson’s disease therapeutics market is fragmented into retail pharmacy, online sales, and hospital pharmacy. The retail pharmacy segment dominated the global market in 2018 and is projected to hold a significant market share in the future.

𝐑𝐞𝐪𝐮𝐞𝐬𝐭 𝐅𝐨𝐫 𝐁𝐫𝐨𝐜𝐡𝐮𝐫𝐞

By region, Europe holds a major share of the global Parkinson’s disease therapeutics market followed by the North American region. Favorable medical reimbursement policies, rising funding and grants for research, high Parkinson’s disease prevalence, and growing awareness about the disease are contributing to the European Parkinson’s disease therapeutics market. In the North American market, alone there are more than 10 different drugs under phase III clinical pipeline studies for treating different symptoms of Parkinson’s disease in the U.S. alone. The Asia Pacific Parkinson’s disease therapeutics market is likely to show a moderate CAGR, owing to a large base of the elderly population suffering from Parkinson’s disease, particularly in China and Japan.

𝐒𝐨𝐦𝐞 𝐩𝐥𝐚𝐲𝐞𝐫𝐬 𝐢𝐧 𝐭𝐡𝐞 𝐠𝐥𝐨𝐛𝐚𝐥 𝐏𝐚𝐫𝐤𝐢𝐧𝐬𝐨𝐧’𝐬 𝐝𝐢𝐬𝐞𝐚𝐬𝐞 𝐭𝐡𝐞𝐫𝐚𝐩𝐞𝐮𝐭𝐢𝐜𝐬 𝐦𝐚𝐫𝐤𝐞𝐭 𝐚𝐫𝐞

Teva Pharmaceutical
STADA Arzneimittel
Impax Laboratories
Novartis F.
Hoffmann-La Roche Merck & Co.
UCB Inc.
GlaxoSmithKline AbbVie
Valeant Pharmaceuticals International.

𝐈𝐧𝐪𝐮𝐢𝐫𝐞 𝐦𝐨𝐫𝐞 𝐚𝐛𝐨𝐮𝐭 𝐭𝐡𝐢𝐬 𝐫𝐞𝐩𝐨𝐫𝐭@https://www.zionmarketresearch.com/inquiry/parkinsons-disease-therapeutics-market

𝐓𝐡𝐢𝐬 𝐫𝐞𝐩𝐨𝐫𝐭 𝐬𝐞𝐠𝐦𝐞𝐧𝐭𝐬 𝐭𝐡𝐞 𝐠𝐥𝐨𝐛𝐚𝐥 𝐏𝐚𝐫𝐤𝐢𝐧𝐬𝐨𝐧’𝐬 𝐝𝐢𝐬𝐞𝐚𝐬𝐞 𝐭𝐡𝐞𝐫𝐚𝐩𝐞𝐮𝐭𝐢𝐜𝐬 𝐦𝐚𝐫𝐤𝐞𝐭 𝐢𝐧𝐭𝐨:

𝐆𝐥𝐨𝐛𝐚𝐥 𝐏𝐚𝐫𝐤𝐢𝐧𝐬𝐨𝐧’𝐬 𝐃𝐢𝐬𝐞𝐚𝐬𝐞 𝐓𝐡𝐞𝐫𝐚𝐩𝐞𝐮𝐭𝐢𝐜𝐬 𝐌𝐚𝐫𝐤𝐞𝐭: 𝐃𝐫𝐮𝐠 𝐂𝐥𝐚𝐬𝐬 𝐀𝐧𝐚𝐥𝐲𝐬𝐢𝐬

Levodopa Combination
Dopamine Agonists
Monoamine Oxidase B (Mao-B) Inhibitors
Anticholinergic Drugs
Catechol-O-Methyltransferase (COMT) Inhibitors
Others

𝐆𝐥𝐨𝐛𝐚𝐥 𝐏𝐚𝐫𝐤𝐢𝐧𝐬𝐨𝐧’𝐬 𝐃𝐢𝐬𝐞𝐚𝐬𝐞 𝐓𝐡𝐞𝐫𝐚𝐩𝐞𝐮𝐭𝐢𝐜𝐬 𝐌𝐚𝐫𝐤𝐞𝐭: 𝐑𝐨𝐮𝐭𝐞 𝐨𝐟 𝐀𝐝𝐦𝐢𝐧𝐢𝐬𝐭𝐫𝐚𝐭𝐢𝐨𝐧 𝐀𝐧𝐚𝐥𝐲𝐬𝐢𝐬

Oral
Transdermal
Subcutaneous
Intestinal Infusion

𝐆𝐥𝐨𝐛𝐚𝐥 𝐏𝐚𝐫𝐤𝐢𝐧𝐬𝐨𝐧’𝐬 𝐃𝐢𝐬𝐞𝐚𝐬𝐞 𝐓𝐡𝐞𝐫𝐚𝐩𝐞𝐮𝐭𝐢𝐜𝐬 𝐌𝐚𝐫𝐤𝐞𝐭: 𝐃𝐢𝐬𝐭𝐫𝐢𝐛𝐮𝐭𝐢𝐨𝐧 𝐂𝐡𝐚𝐧𝐧𝐞𝐥 𝐀𝐧𝐚𝐥𝐲𝐬𝐢𝐬

Hospital Pharmacy
Retail Pharmacy
Online Sales

𝐆𝐥𝐨𝐛𝐚𝐥 𝐏𝐚𝐫𝐤𝐢𝐧𝐬𝐨𝐧’𝐬 𝐃𝐢𝐬𝐞𝐚𝐬𝐞 𝐓𝐡𝐞𝐫𝐚𝐩𝐞𝐮𝐭𝐢𝐜𝐬 𝐌𝐚𝐫𝐤𝐞𝐭: 𝐑𝐞𝐠𝐢𝐨𝐧𝐚𝐥 𝐀𝐧𝐚𝐥𝐲𝐬𝐢𝐬

North America
The U.S.
Europe
UK
France
Germany
Asia Pacific
China
Japan
India
Latin America
Brazil
The Middle East and Africa

Browse the full “𝐏𝐚𝐫𝐤𝐢𝐧𝐬𝐨𝐧’𝐬 𝐃𝐢𝐬𝐞𝐚𝐬𝐞 𝐓𝐡𝐞𝐫𝐚𝐩𝐞𝐮𝐭𝐢𝐜𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐛𝐲 𝐃𝐫𝐮𝐠 𝐂𝐥𝐚𝐬𝐬 (𝐋𝐞𝐯𝐨𝐝𝐨𝐩𝐚 𝐂𝐨𝐦𝐛𝐢𝐧𝐚𝐭𝐢𝐨𝐧, 𝐃𝐨𝐩𝐚𝐦𝐢𝐧𝐞 𝐀𝐠𝐨𝐧𝐢𝐬𝐭𝐬, 𝐌𝐨𝐧𝐨𝐚𝐦𝐢𝐧𝐞 𝐎𝐱𝐢𝐝𝐚𝐬𝐞 𝐁 (𝐌𝐀𝐎-𝐁) 𝐈𝐧𝐡𝐢𝐛𝐢𝐭𝐨𝐫𝐬, 𝐀𝐧𝐭𝐢𝐜𝐡𝐨𝐥𝐢𝐧𝐞𝐫𝐠𝐢𝐜 𝐃𝐫𝐮𝐠𝐬, 𝐂𝐚𝐭𝐞𝐜𝐡𝐨𝐥-𝐎-𝐌𝐞𝐭𝐡𝐲𝐥𝐭𝐫𝐚𝐧𝐬𝐟𝐞𝐫𝐚𝐬𝐞 (𝐂𝐎𝐌𝐓) 𝐈𝐧𝐡𝐢𝐛𝐢𝐭𝐨𝐫𝐬, 𝐚𝐧𝐝 𝐎𝐭𝐡𝐞𝐫𝐬), 𝐛𝐲 𝐑𝐨𝐮𝐭𝐞 𝐨𝐟 𝐀𝐝𝐦𝐢𝐧𝐢𝐬𝐭𝐫𝐚𝐭𝐢𝐨𝐧 (𝐎𝐫𝐚𝐥, 𝐓𝐫𝐚𝐧𝐬𝐝𝐞𝐫𝐦𝐚𝐥, 𝐒𝐮𝐛𝐜𝐮𝐭𝐚𝐧𝐞𝐨𝐮𝐬, 𝐚𝐧𝐝 𝐈𝐧𝐭𝐞𝐬𝐭𝐢𝐧𝐚𝐥 𝐈𝐧𝐟𝐮𝐬𝐢𝐨𝐧), 𝐚𝐧𝐝 𝐛𝐲 𝐃𝐢𝐬𝐭𝐫𝐢𝐛𝐮𝐭𝐢𝐨𝐧 𝐂𝐡𝐚𝐧𝐧𝐞𝐥 (𝐇𝐨𝐬𝐩𝐢𝐭𝐚𝐥 𝐏𝐡𝐚𝐫𝐦𝐚𝐜𝐲, 𝐑𝐞𝐭𝐚𝐢𝐥 𝐏𝐡𝐚𝐫𝐦𝐚𝐜𝐲, 𝐚𝐧𝐝 𝐎𝐧𝐥𝐢𝐧𝐞 𝐒𝐚𝐥𝐞𝐬): 𝐆𝐥𝐨𝐛𝐚𝐥 𝐈𝐧𝐝𝐮𝐬𝐭𝐫𝐲 𝐏𝐞𝐫𝐬𝐩𝐞𝐜𝐭𝐢𝐯𝐞, 𝐂𝐨𝐦𝐩𝐫𝐞𝐡𝐞𝐧𝐬𝐢𝐯𝐞 𝐀𝐧𝐚𝐥𝐲𝐬𝐢𝐬, 𝐚𝐧𝐝 𝐅𝐨𝐫𝐞𝐜𝐚𝐬𝐭, 𝟐𝟎𝟏𝟖–𝟐𝟎𝟐𝟓” 𝐑𝐞𝐩𝐨𝐫𝐭 𝐚𝐭
https://www.zionmarketresearch.com/report/parkinsons-disease-therapeutics-market

𝐓𝐡𝐞 𝐫𝐞𝐩𝐨𝐫𝐭𝐬 𝐨𝐟𝐟𝐞𝐫 𝐚𝐧𝐬𝐰𝐞𝐫𝐬 𝐭𝐨 𝐭𝐡𝐞 𝐭𝐨𝐩 𝟕 𝐪𝐮𝐞𝐬𝐭𝐢𝐨𝐧𝐬 𝐭𝐡𝐚𝐭 𝐫𝐞𝐯𝐨𝐥𝐯𝐞 𝐚𝐫𝐨𝐮𝐧𝐝 𝐭𝐡𝐞 𝐠𝐫𝐨𝐰𝐭𝐡 𝐨𝐟 𝐭𝐡𝐞 𝐦𝐚𝐫𝐤𝐞𝐭

What different growth factors are influencing the market?

-Which geographic areas will have a significant impact on the market's expansion

-What technological improvements and current innovations have been made in the market?

What new trends are you seeing in the market?

What impact has COVID-19 had on the market?

What will the market look like after the pandemic?

What are the main dangers that the market's growth prospects face?

𝐑𝐞𝐚𝐝 𝐍𝐞𝐰𝐬@https://www.zionmarketresearch.com/news/parkinsons-disease-therapeutics-market

𝐖𝐡𝐚𝐭 𝐑𝐞𝐩𝐨𝐫𝐭𝐬 𝐏𝐫𝐨𝐯𝐢𝐝𝐞𝐬

a comprehensive examination of the parent market

significant alterations in market dynamics

Market segmentation information

Market study in terms of volume and value from the past, present, and future

Evaluation of developments in specialist industries

Analyses of market shares

crucial tactics used by important players

regional marketplaces and emerging segments

𝐑𝐞𝐥𝐚𝐭𝐞𝐝 𝐏𝐫𝐞𝐬𝐬 𝐑𝐞𝐥𝐞𝐚𝐬𝐞
Healthcare Business Intelligence (BI) Market
https://www.einpresswire.com/article/594128807/global-healthcare-business-intelligence-bi-market-analysis-to-accounted-for-value-around-usd-10-117-mn-by-2025

https://www.linkedin.com/pulse/global-colorants-market-research-report-covers-future-jon-sena/

https://www.linkedin.com/pulse/global-bioethanol-market-passenger-cars-2022-worldwide-jon-sena/

DNA and Gene Chips@https://www.openpr.com/news/2760082/global-dna-and-gene-chips-market-industry-trends-size-scope

Kajal Rupnar
Zion Market Research
+ +18554654651 ext.
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.